Sunday 21 January 2018 ShareProphets: The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

Optibiotix - funny old day, wait for the next news

By HotStockRockets | Thursday 8 October 2015

Disclosure: Financial Investigative Media Limited, which is not owned by Tom Winnifrith but by a trust for his dependants, owns shares in companies mentioned in this article. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.

OptiBiotix Health (OPTI) has announced the registration of five new microbial strains under the Budapest Treaty, increasing the number of registrations to eight, to protect the “recent advances” the company notes to have made.

Administered by the World Intellectual Property Organisation, the international Budapest Treaty enables the deposition of micro-organisms for the purposes of patent protection, providing a reference point for filing and defending patents and establishing title during commercial discussions. This latest move here follows the noted five strains having been identified as having the potential to generate novel oligosaccharides (carbohydrates that consist of a small number of sugars).

The company announced in July an agreement for the scaling up, purification and testing for organoleptic (taste, texture, aftertaste) and microbiome modulating properties of oligosaccharides from strains showing commercial potential.  It now notes that “this work is the final stages of the laboratory programme which will enable OptiBiotix to progress its pipeline of novel oligosaccharides to testing in human studies”.

CEO Stephen O'Hara adds that “with our cholesterol product moving to pilot manufacture and our sugar development programmes moving towards clinical studies, we are making good progress in multiple product and partnering opportunities". We recently updated on the cholesterol product – noting at 40p, that we considered shares in OptiBiotix a buy at up to 42p, with a target of 50p. They are now at 46.75p and the progress being made sees us ever more confident of a 50p+ valuation.

At midday the Finance Yorkshire Seedcorn Fund (FYSF) announced hat on 25 September it had cut its stake from c14 million shares to c12.6 million which is still 17% of the company. This prompted a mini sell off on fears that there is a large overhang. There is not. FYSF was an original seed investor and was taking out £600,000 which was its original stake so it is now in for free. That was all well "choreographed" with other investors. So there is no overhang and we are expecting another VERY BIG announcement within the next week or so.

This material first appeared on Hot Stock Rockets when the shares were 3.75p offer - sorry its paying customers first. Hot Stock Rockets will be serving up its next red hot share tip shortly. To access the UK’s fastest growing share tipping website for less than £5 a month ( or for £5 for one month)   click HERE

Filed under:

Never miss a story.

This area of the site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.

More on OPTI



  1. You could srape some mold off your cheese and make a Budapest Treaty deposit. It costs a couple of thousand USD for thirty years and of itself provides no legal protection and there is no examination of the utility of the deposited material. It can be useful in obtaining patent protection and patents can protect innovation but beither is a given.

    Saying you’ve made a Budapest deposit sounds like a bit of a ramp to me.

Enter your comment below. Fields marked * are required. You must preview your comment first before finally posting.

Site by Everywhen